Dan Gorenstein

New regulations designed to crack down on misleading marketing of Medicare insurance plans face their first big test when seniors begin shopping for coverage on Oct. 15.

The quick rise in popularity of the diabetes drugs used for weight loss over the last two years caught many employers flat footed. Now, employers are scrambling to find solutions to help improve worker health while simultaneously keeping a lid on rising health care spending.

A bipartisan group of lawmakers agree: Medicare and Medicaid are failing 12 million of the country's most vulnerable patients.

Girls in the U.S. are experiencing record high levels of violence, sadness and suicide risk. A school-based program is helping them.

What’s a fair price to pay for prescription drugs? Medicare will soon face this and other tough questions when it begins historic price negotiations with drugmakers.

Last July, the cumbersome 10-digit National Suicide Prevention Lifeline became 988. At the one-year mark, there’s some success to report: Texts to the lifeline increased dramatically and average wait times across the line plummeted from 2 minutes 39 seconds to 41 seconds.

The rapid growth of private Medicare Advantage plans is raising questions about what care could — and should — look like for all 80 million people expected to be on Medicare by 2030.

Artificial intelligence could revolutionize health care. It could also perpetuate and exacerbate generations of racial inequities.

Congress is considering legislation that would cut the prices Medicare pays hospitals for some common outpatient services like X-rays, injections and check-ups.

A federal pilot project tests handing the reins of some hospice care over to private insurers. The experiment, which began in 2021, could ultimately transform the end of life care available to millions of Americans.